Diabetes Care 2005-Feb
Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab.
Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard